Viscosupplementation & Hybrid Protocols
Combined biologic and hyaluronic-acid regimens tailored to stage of joint disease, activity level, and surgical timeline.
What It Is / How It Works
Viscosupplementation involves the intra-articular injection of hyaluronic acid (HA) — a naturally occurring component of synovial fluid — to supplement the degraded joint environment seen in osteoarthritis. As articular cartilage breaks down, synovial fluid loses its viscoelastic properties, increasing joint friction and inflammation. Exogenous HA restores lubrication, acts as a mechanical shock absorber, and exerts direct anti-inflammatory and chondroprotective effects through HA receptor signaling.
Hybrid protocols combine HA with PRP in a single treatment session or sequential injection series. This approach leverages the structural/lubricating benefits of HA with the growth factor-mediated healing signal of PRP — particularly useful in moderate-stage osteoarthritis where both cartilage protection and tissue repair signaling are needed. Protocol selection is individualized based on Kellgren-Lawrence grade, prior injection history, functional demands, and surgical planning timeline.
Who Is a Candidate
Hyaluronic acid injection is best established for patients with mild-to-moderate knee osteoarthritis, generally Kellgren-Lawrence grades I through III, who have had an inadequate response to activity modification, physical therapy, or oral anti-inflammatory medication. Hybrid HA-plus-PRP protocols may be considered for patients seeking a combined lubricating and biologic approach, particularly those who have had a partial or short-lived response to either therapy alone.
Patients with advanced, bone-on-bone arthritis are less likely to benefit meaningfully from viscosupplementation, and those with active joint infection, known hypersensitivity to hyaluronan products, or significant inflammatory arthropathy are generally not candidates. Patients should also understand that the evidence supporting HA is genuinely mixed, with some large trials showing only modest benefit over placebo, and this is discussed openly as part of shared decision-making before proceeding.
What to Expect
Viscosupplementation is performed in the office setting as an ultrasound-guided intra-articular injection into the affected joint, most commonly the knee, with a course consisting of a single injection or a short series depending on the specific HA product used. When a hybrid protocol is planned, PRP is prepared from a blood draw processed by centrifugation, as described on the PRP page, and the two components may be combined or given in a staged sequence per the treating physician's protocol.
The visit itself typically takes thirty minutes to an hour depending on whether PRP preparation is also required. A temporary increase in joint swelling or discomfort, sometimes called a post-injection flare, can occur in the days following treatment and is managed conservatively. Patients are generally advised to avoid high-impact activity for a short period and to resume normal activity gradually as symptoms allow.
Evidence Base
- Viscosupplementation for knee osteoarthritis: systematic review and meta-analysis. PMID: 36333100 ↗
- Effects and safety of the combination of platelet-rich plasma (PRP) and hyaluronic acid (HA) in the treatment of knee osteoarthritis: a systematic review and meta-analysis. PMID: 32278352 ↗
- Efficacy of the combination therapy of platelet-rich plasma and hyaluronic acid on improving knee pain and dysfunction in patients with moderate-to-severe KOA: a protocol for a randomised controlled trial. PMID: 37336540 ↗
- Systematic Literature Review and Expert Opinion for the Use of Viscosupplementation with Hyaluronic Acid in Different Localizations of Osteoarthritis. PMID: 34880685 ↗
Interested in learning whether this treatment is appropriate for you?
Request a Consultation ↗